Updated Jul 16, 2026
LINDSTROM RICHARD L MD has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $531K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | OCUL | OCULAR THERAPEUTIX, INC | A — Grant or award | 14.0K | $0.00 | |
| 2026-06-05 | LNSR | LENSAR, Inc. | A — Grant or award | 17.4K | $0.00 | |
| 2026-02-24 | OCUL | OCULAR THERAPEUTIX, INC | P — Open-market purchase | 60.2K | $7.66 | $461K |
| 2025-06-11 | OCUL | OCULAR THERAPEUTIX, INC | A — Grant or award | 14.0K | $0.00 | |
| 2025-05-23 | LNSR | LENSAR, Inc. | A — Grant or award | 7.4K | $0.00 | |
| 2025-05-08 | OCUL | OCULAR THERAPEUTIX, INC | P — Open-market purchase | 10.0K | $6.96 | $70K |
LINDSTROM RICHARD L MD is a corporate insider — currently tracked as Director of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($531K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LINDSTROM RICHARD L MD profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.